Connect with us:
We're making headlines
We're on a mission to transform medical research, for good. And people are taking notice.
Business Insider: "Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology."
Antidote Technologies’ Business Development Leader Dave Mauro Named to the 2021 PharmaVOICE 100
Vator News: Today's entrepreneur: Laurent Schockmel, CEO of Antidote
Vator News: "Antidote raises $23M to match patients with clinical trials"
Press release: "Antidote Raises $23 Million to Scale Digital Patient Engagement Services"
Press Release: "Antidote Technologies Registers Over 40,000 COPD Patients for Clinical Trial Matching Services"
Press release: "Antidote Technologies Drives Patient Recruitment for Three Pivotal COVID-19 Clinical Trials"
Press release: "Antidote Technologies Spearheads Recruitment for a COVID Early Treatment Fund Clinical Trial Recently Featured on CBS Program 60 Minutes"
Press release: "Antidote Technologies named a top innovator in new book for pharma industry"
PharmaVOICE 100: "Laurent Schockmel, Creating Transformative Connections"